difference between tirzepatide vs semaglutide Tirzepatide: Key Differences Tirzepatide vs. Ozempic: Comparing Diabetes

Pep is a GLP-1 tracker app designed to help people track medications like Ozempic, Wegovy, Zepbound, and Mounjaro

Two GLP-1R agonists have been approved in the United States to treat obesity: semaglutide and LIR, both of which are injected subcutaneously

The overlapping side effect profiles and distinct mechanisms of action create risks that may be additive or synergistic

The process begins with a comprehensive consultation with one of our providers, where well review your medical history and discuss your weight loss goals

Another severe reaction is anaphylaxis, a dangerous condition that affects breathing

Semaglutide A GLP-1 receptor agonist that mimics a natural hormone in your body to control appetite and blood sugar Administered as a weekly injection Proven effective for weight loss in clinical trials Also approved for type 2 diabetes management Tirzepatide Dual GLP-1/GIP receptor agonist, meaning it targets two key hormones for even greater potential weight loss